The Role and Mechanism of Estrogen in Perimenopausal Depression

Depression is a severe psychiatric disorder characterized by high prevalence rates, elevated suicide risks, and significant relapse rates. Women, particularly during the perimenopausal period, are more vulnerable to developing depression. Fluctuations in estrogen levels during perimenopause can heighten a woman's sensitivity to psychosocial stress. Clinical trials have demonstrated the short-term antidepressant efficacy of estradiol in perimenopausal women. However, the precise mechanisms through which estrogen influences mood disorders during perimenopause remain unclear. This review summarizes the risk factors associated with perimenopausal depression (PMD), examines current research on estrogen therapy, and explores the potential mechanisms and related pathological processes involved in estrogen's role in treating depression. Understanding how estrogen mitigates depressive symptoms in perimenopausal women may help reduce the morbidity and mortality associated with PMD while also alleviating its socioeconomic burden.

Authors

Institutions

Publication Details

Journal
Current Neuropharmacology
Published
2025-04-24
DOI
https://doi.org/10.2174/011570159x371863250327073835
Citations
2
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
2.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Role and Mechanism of Estrogen in Perimenopausal Depression

Ranji Cui, Bingqing Guan, Wei Yang, Xiying Fu et al.
2 citations
Current Neuropharmacology
Menopause: Health Impacts and Treatments
2.59
article

The Role and Mechanism of Estrogen in Perimenopausal Depression

Ranji Cui, Bingqing Guan, Wei Yang, Xiying Fu, Yaqi Liu
article en
2 citations

Abstract

Depression is a severe psychiatric disorder characterized by high prevalence rates, elevated suicide risks, and significant relapse rates. Women, particularly during the perimenopausal period, are more vulnerable to developing depression. Fluctuations in estrogen levels during perimenopause can heighten a woman's sensitivity to psychosocial stress. Clinical trials have demonstrated the short-term antidepressant efficacy of estradiol in perimenopausal women. However, the precise mechanisms through which estrogen influences mood disorders during perimenopause remain unclear. This review summarizes the risk factors associated with perimenopausal depression (PMD), examines current research on estrogen therapy, and explores the potential mechanisms and related pathological processes involved in estrogen's role in treating depression. Understanding how estrogen mitigates depressive symptoms in perimenopausal women may help reduce the morbidity and mortality associated with PMD while also alleviating its socioeconomic burden.

Current NeuropharmacologyVol. 23(1)
Second Affiliated Hospital of Jilin University (CN)
Good health and well-being
Openalex Percentile: Top 11%
Menopause: Health Impacts and Treatments
2.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Role and Mechanism of Estrogen in Perimenopausal Depression — Ranji Cui, Bingqing Guan, et al. · Current Neuropharmacology (2025) | TGRS Research Map | TGRS